Revance Therapeutics reported -1.1 in EPS Earnings Per Share for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Abbvie ABBV:US $ 0K 0K
Adamas Pharmaceuticals ADMS:US -0.43 0.16
Aerie Pharmaceuticals AERI:US -0.72 0.05
ALKERMES ALKS:US $ 0.14 0.16
Antares Pharma ATRS:US 0.03 0
Biodelivery Sciences International BDSI:US 0.07 0.02
Bristol Myers Squibb BMY:US $ 2 0.07
Cara Therapeutics CARA:US -0.02 0.59
Coherus Biosciences CHRS:US $ -0.34 0.02
Eli Lilly And LLY:US $ 1.94 0.07
Endo International Ordinary Shares ENDP:US $ 0.8 0.15
Flexion Therapeutics FLXN:US -0.6 0.16
Gw Pharmaceuticals GWPH:US $ -0.05 0.91
Horizon Pharma HZNP:US $ 1.75 0.13
JAZZ PHA JAZZ:US $ 4.2 0.3
Johnson & Johnson JNJ:US 2.6 0.12
Merk MRK:US $ 1.75 0.44
Neurocrine Biosciences NBIX:US $ 0.64 0.21
Pacira Pharmaceuticals PCRX:US $ 0.72 0.05
Procter & Gamble PG:US $ 1.61 0.48
Revance Therapeutics RVNC:US -1.1 0.03
Supernus Pharmaceuticals SUPN:US 0.4 0.03
Teva Pharmaceutical Industries TEVA:US $ 0.59 0
Zogenix ZGNX:US -1.04 0.01